As of 2024-12-12, the Relative Valuation of Insmed Inc (INSM) is (103.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 74.20 USD, the upside of Insmed Inc based on Relative Valuation is -239.0%.
The range of the Relative Valuation is (97.30) - (114.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 24.8x | 20.8x |
| Forward P/E multiples | 20.1x - 23.6x | 21.9x |
| Fair Price | (97.30) - (114.01) | (103.14) |
| Upside | -231.1% - -253.7% | -239.0% |
| Date | P/E |
| 2024-12-10 | -15.03 |
| 2024-12-09 | -15.06 |
| 2024-12-06 | -15.61 |
| 2024-12-05 | -15.59 |
| 2024-12-04 | -15.60 |
| 2024-12-03 | -14.99 |
| 2024-12-02 | -14.99 |
| 2024-11-29 | -15.56 |
| 2024-11-27 | -15.71 |
| 2024-11-26 | -15.67 |
| 2024-11-25 | -15.34 |
| 2024-11-22 | -15.14 |
| 2024-11-21 | -15.28 |
| 2024-11-20 | -15.04 |
| 2024-11-19 | -15.26 |
| 2024-11-18 | -13.79 |
| 2024-11-15 | -13.72 |
| 2024-11-14 | -14.75 |
| 2024-11-13 | -14.61 |
| 2024-11-12 | -14.52 |
| 2024-11-11 | -14.87 |
| 2024-11-08 | -15.22 |
| 2024-11-07 | -14.84 |
| 2024-11-06 | -15.08 |
| 2024-11-05 | -14.34 |
| 2024-11-04 | -14.09 |
| 2024-11-01 | -14.14 |
| 2024-10-31 | -13.93 |
| 2024-10-30 | -14.55 |
| 2024-10-29 | -14.69 |
| 2024-10-28 | -14.90 |
| 2024-10-25 | -14.69 |
| 2024-10-24 | -14.84 |
| 2024-10-23 | -14.89 |
| 2024-10-22 | -15.25 |
| 2024-10-21 | -14.96 |
| 2024-10-18 | -15.43 |
| 2024-10-17 | -15.37 |
| 2024-10-16 | -15.87 |
| 2024-10-15 | -15.45 |
| 2024-10-14 | -15.54 |
| 2024-10-11 | -15.43 |
| 2024-10-10 | -14.84 |
| 2024-10-09 | -14.48 |
| 2024-10-08 | -14.77 |
| 2024-10-07 | -14.59 |
| 2024-10-04 | -14.96 |
| 2024-10-03 | -14.78 |
| 2024-10-02 | -15.11 |
| 2024-10-01 | -15.09 |